JP2599161B2 - Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultry - Google Patents
Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultryInfo
- Publication number
- JP2599161B2 JP2599161B2 JP62328331A JP32833187A JP2599161B2 JP 2599161 B2 JP2599161 B2 JP 2599161B2 JP 62328331 A JP62328331 A JP 62328331A JP 32833187 A JP32833187 A JP 32833187A JP 2599161 B2 JP2599161 B2 JP 2599161B2
- Authority
- JP
- Japan
- Prior art keywords
- crude drug
- therapeutic agent
- preventive
- livestock
- poultry
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000003814 drug Substances 0.000 title claims description 51
- 244000144977 poultry Species 0.000 title claims description 15
- 244000144972 livestock Species 0.000 title claims description 14
- 230000003449 preventive effect Effects 0.000 title claims description 8
- 229940124597 therapeutic agent Drugs 0.000 title claims description 8
- 206010061043 Clostridial infection Diseases 0.000 title description 10
- 208000037384 Clostridium Infections Diseases 0.000 title description 9
- 229940079593 drug Drugs 0.000 claims description 39
- 239000000284 extract Substances 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 19
- 235000013594 poultry meat Nutrition 0.000 claims description 14
- 208000015181 infectious disease Diseases 0.000 claims description 13
- 239000003960 organic solvent Substances 0.000 claims description 12
- 241000736199 Paeonia Species 0.000 claims description 10
- 239000003795 chemical substances by application Substances 0.000 claims description 10
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 9
- 241001116389 Aloe Species 0.000 claims description 8
- 241000218671 Ephedra Species 0.000 claims description 8
- 241000555712 Forsythia Species 0.000 claims description 8
- 241000287828 Gallus gallus Species 0.000 claims description 8
- 244000303040 Glycyrrhiza glabra Species 0.000 claims description 8
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 8
- 240000002657 Thymus vulgaris Species 0.000 claims description 8
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 8
- 239000004480 active ingredient Substances 0.000 claims description 8
- 235000011399 aloe vera Nutrition 0.000 claims description 8
- 239000001585 thymus vulgaris Substances 0.000 claims description 8
- 235000003261 Artemisia vulgaris Nutrition 0.000 claims description 7
- 240000006891 Artemisia vulgaris Species 0.000 claims description 7
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 7
- 244000300264 Spinacia oleracea Species 0.000 claims description 7
- 235000013330 chicken meat Nutrition 0.000 claims description 7
- 235000005491 Geranium thunbergii Nutrition 0.000 claims description 6
- 244000105059 Geranium thunbergii Species 0.000 claims description 6
- 244000025221 Humulus lupulus Species 0.000 claims description 6
- 241000282887 Suidae Species 0.000 claims description 6
- 244000299790 Rheum rhabarbarum Species 0.000 claims description 5
- 235000009411 Rheum rhabarbarum Nutrition 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 4
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 4
- 241000193403 Clostridium Species 0.000 claims description 3
- 235000011477 liquorice Nutrition 0.000 claims description 3
- 230000000069 prophylactic effect Effects 0.000 claims description 3
- 241001494479 Pecora Species 0.000 claims description 2
- 241000282412 Homo Species 0.000 description 21
- 201000010099 disease Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 239000004615 ingredient Substances 0.000 description 14
- 241000193468 Clostridium perfringens Species 0.000 description 13
- 238000000034 method Methods 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 241001465754 Metazoa Species 0.000 description 10
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- 206010012735 Diarrhoea Diseases 0.000 description 8
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical class OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 8
- 230000000202 analgesic effect Effects 0.000 description 8
- 239000002221 antipyretic Substances 0.000 description 8
- 239000003242 anti bacterial agent Substances 0.000 description 7
- 230000001754 anti-pyretic effect Effects 0.000 description 7
- 239000002934 diuretic Substances 0.000 description 7
- -1 α-thuyon Natural products 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000001882 diuretic effect Effects 0.000 description 6
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000001648 tannin Substances 0.000 description 6
- 229920001864 tannin Polymers 0.000 description 6
- 235000018553 tannin Nutrition 0.000 description 6
- 239000000341 volatile oil Substances 0.000 description 6
- 208000004998 Abdominal Pain Diseases 0.000 description 5
- 244000061508 Eriobotrya japonica Species 0.000 description 5
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 210000002784 stomach Anatomy 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 240000001980 Cucurbita pepo Species 0.000 description 4
- 235000009852 Cucurbita pepo Nutrition 0.000 description 4
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 4
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 4
- 241000282898 Sus scrofa Species 0.000 description 4
- 230000003110 anti-inflammatory effect Effects 0.000 description 4
- 239000007799 cork Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 4
- 229940010454 licorice Drugs 0.000 description 4
- 239000003208 petroleum Substances 0.000 description 4
- 230000002265 prevention Effects 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 230000001256 tonic effect Effects 0.000 description 4
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 244000194101 Ginkgo biloba Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000008694 Humulus lupulus Nutrition 0.000 description 3
- 241000612118 Samolus valerandi Species 0.000 description 3
- 244000223014 Syzygium aromaticum Species 0.000 description 3
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 3
- 230000000954 anitussive effect Effects 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 230000002921 anti-spasmodic effect Effects 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 229940124584 antitussives Drugs 0.000 description 3
- 208000006673 asthma Diseases 0.000 description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 3
- 230000003115 biocidal effect Effects 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- PCHPORCSPXIHLZ-UHFFFAOYSA-N diphenhydramine hydrochloride Chemical compound [Cl-].C=1C=CC=CC=1C(OCC[NH+](C)C)C1=CC=CC=C1 PCHPORCSPXIHLZ-UHFFFAOYSA-N 0.000 description 3
- 235000004515 gallic acid Nutrition 0.000 description 3
- 229940074391 gallic acid Drugs 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 239000001630 malic acid Substances 0.000 description 3
- 235000011090 malic acid Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000001624 sedative effect Effects 0.000 description 3
- 241000894007 species Species 0.000 description 3
- XMGQYMWWDOXHJM-JTQLQIEISA-N (+)-α-limonene Chemical compound CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 2
- GRWFGVWFFZKLTI-IUCAKERBSA-N (-)-α-pinene Chemical compound CC1=CC[C@@H]2C(C)(C)[C@H]1C2 GRWFGVWFFZKLTI-IUCAKERBSA-N 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 2
- PCBSXBYCASFXTM-UHFFFAOYSA-N 4-(4-Methoxyphenyl)-2-butanone Chemical compound COC1=CC=C(CCC(C)=O)C=C1 PCBSXBYCASFXTM-UHFFFAOYSA-N 0.000 description 2
- SCCDQYPEOIRVGX-UHFFFAOYSA-N Acetyleugenol Chemical compound COC1=CC(CC=C)=CC=C1OC(C)=O SCCDQYPEOIRVGX-UHFFFAOYSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000271566 Aves Species 0.000 description 2
- 235000008499 Canella winterana Nutrition 0.000 description 2
- 244000080208 Canella winterana Species 0.000 description 2
- KUJLPCYCQICVRM-UHFFFAOYSA-N Capillarin Chemical compound C1=CC=C2C(=O)OC(CC#CC)=CC2=C1 KUJLPCYCQICVRM-UHFFFAOYSA-N 0.000 description 2
- VWDXGKUTGQJJHJ-UHFFFAOYSA-N Catenarin Natural products C1=C(O)C=C2C(=O)C3=C(O)C(C)=CC(O)=C3C(=O)C2=C1O VWDXGKUTGQJJHJ-UHFFFAOYSA-N 0.000 description 2
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000010282 Emodin Substances 0.000 description 2
- RBLJKYCRSCQLRP-UHFFFAOYSA-N Emodin-dianthron Natural products O=C1C2=CC(C)=CC(O)=C2C(=O)C2=C1CC(=O)C=C2O RBLJKYCRSCQLRP-UHFFFAOYSA-N 0.000 description 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 2
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 2
- 239000005770 Eugenol Substances 0.000 description 2
- 235000019733 Fish meal Nutrition 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- YOOXNSPYGCZLAX-UHFFFAOYSA-N Helminthosporin Natural products C1=CC(O)=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O YOOXNSPYGCZLAX-UHFFFAOYSA-N 0.000 description 2
- 241001183967 Isodon Species 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 235000009134 Myrica cerifera Nutrition 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 2
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 2
- NTGIIKCGBNGQAR-UHFFFAOYSA-N Rheoemodin Natural products C1=C(O)C=C2C(=O)C3=CC(O)=CC(O)=C3C(=O)C2=C1O NTGIIKCGBNGQAR-UHFFFAOYSA-N 0.000 description 2
- 244000061457 Solanum nigrum Species 0.000 description 2
- 235000019764 Soybean Meal Nutrition 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 2
- 244000269722 Thea sinensis Species 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 230000000507 anthelmentic effect Effects 0.000 description 2
- 230000001142 anti-diarrhea Effects 0.000 description 2
- 229940124599 anti-inflammatory drug Drugs 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- AKGGYBADQZYZPD-UHFFFAOYSA-N benzylacetone Chemical compound CC(=O)CCC1=CC=CC=C1 AKGGYBADQZYZPD-UHFFFAOYSA-N 0.000 description 2
- YBHILYKTIRIUTE-UHFFFAOYSA-N berberine Chemical compound C1=C2CC[N+]3=CC4=C(OC)C(OC)=CC=C4C=C3C2=CC2=C1OCO2 YBHILYKTIRIUTE-UHFFFAOYSA-N 0.000 description 2
- 229940093265 berberine Drugs 0.000 description 2
- QISXPYZVZJBNDM-UHFFFAOYSA-N berberine Natural products COc1ccc2C=C3N(Cc2c1OC)C=Cc4cc5OCOc5cc34 QISXPYZVZJBNDM-UHFFFAOYSA-N 0.000 description 2
- 210000000941 bile Anatomy 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- RAZOKRUZEQERLH-UHFFFAOYSA-N capillin Chemical compound CC#CC#CC(=O)C1=CC=CC=C1 RAZOKRUZEQERLH-UHFFFAOYSA-N 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 2
- 229930007050 cineol Natural products 0.000 description 2
- 229960005233 cineole Drugs 0.000 description 2
- 229940017545 cinnamon bark Drugs 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- RHMXXJGYXNZAPX-UHFFFAOYSA-N emodin Chemical compound C1=C(O)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O RHMXXJGYXNZAPX-UHFFFAOYSA-N 0.000 description 2
- VASFLQKDXBAWEL-UHFFFAOYSA-N emodin Natural products OC1=C(OC2=C(C=CC(=C2C1=O)O)O)C1=CC=C(C=C1)O VASFLQKDXBAWEL-UHFFFAOYSA-N 0.000 description 2
- 208000029182 enterotoxemia Diseases 0.000 description 2
- 229960002217 eugenol Drugs 0.000 description 2
- 239000004467 fishmeal Substances 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000008141 laxative Substances 0.000 description 2
- 230000002475 laxative effect Effects 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- VVOAZFWZEDHOOU-UHFFFAOYSA-N magnolol Chemical compound OC1=CC=C(CC=C)C=C1C1=CC(CC=C)=CC=C1O VVOAZFWZEDHOOU-UHFFFAOYSA-N 0.000 description 2
- 230000003211 malignant effect Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229940100243 oleanolic acid Drugs 0.000 description 2
- PKUBGLYEOAJPEG-UHFFFAOYSA-N physcion Natural products C1=C(C)C=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O PKUBGLYEOAJPEG-UHFFFAOYSA-N 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 2
- GPTFURBXHJWNHR-UHFFFAOYSA-N protopine Chemical compound C1=C2C(=O)CC3=CC=C4OCOC4=C3CN(C)CCC2=CC2=C1OCO2 GPTFURBXHJWNHR-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000000932 sedative agent Substances 0.000 description 2
- 210000000813 small intestine Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 239000004455 soybean meal Substances 0.000 description 2
- 235000002906 tartaric acid Nutrition 0.000 description 2
- 239000011975 tartaric acid Substances 0.000 description 2
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 2
- MGSRCZKZVOBKFT-UHFFFAOYSA-N thymol Chemical compound CC(C)C1=CC=C(C)C=C1O MGSRCZKZVOBKFT-UHFFFAOYSA-N 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 2
- PXMNUDOKAWZSJH-AWEZNQCLSA-N (+)-Domestine Natural products O(C)c1c(OC)cc2c3[C@@H]([N+](C)CC2)Cc2c(-c13)cc1OCOc1c2 PXMNUDOKAWZSJH-AWEZNQCLSA-N 0.000 description 1
- KWGRBVOPPLSCSI-WPRPVWTQSA-N (-)-ephedrine Chemical compound CN[C@@H](C)[C@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WPRPVWTQSA-N 0.000 description 1
- SDOFMBGMRVAJNF-KVTDHHQDSA-N (2r,3r,4r,5r)-6-aminohexane-1,2,3,4,5-pentol Chemical compound NC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO SDOFMBGMRVAJNF-KVTDHHQDSA-N 0.000 description 1
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 description 1
- APQIUTYORBAGEZ-UHFFFAOYSA-N 1,1-dibromoethane Chemical compound CC(Br)Br APQIUTYORBAGEZ-UHFFFAOYSA-N 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- GICIECWTEWJCRE-UHFFFAOYSA-N 3,4,4,7-tetramethyl-2,3-dihydro-1h-naphthalene Chemical compound CC1=CC=C2C(C)(C)C(C)CCC2=C1 GICIECWTEWJCRE-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241001290610 Abildgaardia Species 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000004509 Aloe arborescens Nutrition 0.000 description 1
- 240000007474 Aloe arborescens Species 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- 208000031295 Animal disease Diseases 0.000 description 1
- 241000271307 Aquilaria malaccensis Species 0.000 description 1
- 235000015701 Artemisia arbuscula Nutrition 0.000 description 1
- 241000092668 Artemisia capillaris Species 0.000 description 1
- 235000008658 Artemisia capillaris Nutrition 0.000 description 1
- 235000017519 Artemisia princeps Nutrition 0.000 description 1
- 244000065027 Artemisia princeps Species 0.000 description 1
- 235000002657 Artemisia tridentata Nutrition 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000244186 Ascaris Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 208000031729 Bacteremia Diseases 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- 244000037364 Cinnamomum aromaticum Species 0.000 description 1
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 244000223760 Cinnamomum zeylanicum Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 235000003913 Coccoloba uvifera Nutrition 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000218203 Coptis japonica Species 0.000 description 1
- 241000209020 Cornus Species 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- 244000301850 Cupressus sempervirens Species 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 241000208296 Datura Species 0.000 description 1
- 235000008375 Decussocarpus nagi Nutrition 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 241001465251 Ephedra sinica Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017711 Gangrene Diseases 0.000 description 1
- 208000018522 Gastrointestinal disease Diseases 0.000 description 1
- 244000275701 Geranium nepalense Species 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- RMFGNMMNUZWCRZ-UHFFFAOYSA-N Humulone Natural products CC(C)CC(=O)C1=C(O)C(O)(CC=C(C)C)C(O)=C(CC=C(C)C)C1=O RMFGNMMNUZWCRZ-UHFFFAOYSA-N 0.000 description 1
- 241000218228 Humulus Species 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- 241000735234 Ligustrum Species 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- OLHLJBVALXTBSQ-UHFFFAOYSA-N Lupulone Natural products CC(C)CC(=O)C1C(=O)C(CC=C(C)C)C(=O)C(CC=C(C)C)(CC=C(C)C)C1=O OLHLJBVALXTBSQ-UHFFFAOYSA-N 0.000 description 1
- 241000218378 Magnolia Species 0.000 description 1
- 240000004580 Magnolia hypoleuca Species 0.000 description 1
- 235000014196 Magnolia kobus Nutrition 0.000 description 1
- 240000005378 Magnolia kobus Species 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 208000037093 Menstruation Disturbances Diseases 0.000 description 1
- 206010027339 Menstruation irregular Diseases 0.000 description 1
- 241000536568 Metanephrops japonicus Species 0.000 description 1
- XOBKSJJDNFUZPF-UHFFFAOYSA-N Methoxyethane Chemical compound CCOC XOBKSJJDNFUZPF-UHFFFAOYSA-N 0.000 description 1
- 102000001621 Mucoproteins Human genes 0.000 description 1
- 108010093825 Mucoproteins Proteins 0.000 description 1
- 244000132436 Myrica rubra Species 0.000 description 1
- 235000014631 Myrica rubra Nutrition 0.000 description 1
- IKMDFBPHZNJCSN-UHFFFAOYSA-N Myricetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC(O)=C(O)C(O)=C1 IKMDFBPHZNJCSN-UHFFFAOYSA-N 0.000 description 1
- 240000007695 Nandina domestica Species 0.000 description 1
- 241001602876 Nata Species 0.000 description 1
- 206010028851 Necrosis Diseases 0.000 description 1
- 206010051606 Necrotising colitis Diseases 0.000 description 1
- 241000318798 Negeta Species 0.000 description 1
- 208000030880 Nose disease Diseases 0.000 description 1
- 241000534297 Nothosmyrnium Species 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 1
- 241001474977 Palla Species 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 235000004348 Perilla frutescens Nutrition 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 241001600434 Plectroglyphidodon lacrymatus Species 0.000 description 1
- WWEICYMHWQAHOS-UHFFFAOYSA-N Protopin Natural products CN1CCc2cc3OCOc3cc2C(=O)CCc4cc5OCOc5cc14 WWEICYMHWQAHOS-UHFFFAOYSA-N 0.000 description 1
- GTRPODKMSBFDOI-UHFFFAOYSA-N Protopine Natural products CN1Cc2c3OCOc3ccc2C4C1Cc5cc6OCOc6cc5C4=O GTRPODKMSBFDOI-UHFFFAOYSA-N 0.000 description 1
- ZAALQOFZFANFTF-UHFFFAOYSA-N Pseudoprotipine Natural products C1=C2C(=O)CC3=CC=4OCOC=4C=C3CN(C)CCC2=CC2=C1OCO2 ZAALQOFZFANFTF-UHFFFAOYSA-N 0.000 description 1
- 239000009223 Psyllium Substances 0.000 description 1
- 240000008976 Pterocarpus marsupium Species 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008090 Rheum palmatum Nutrition 0.000 description 1
- 240000001745 Rheum palmatum Species 0.000 description 1
- 240000003152 Rhus chinensis Species 0.000 description 1
- 235000014220 Rhus chinensis Nutrition 0.000 description 1
- 235000010889 Rhus javanica Nutrition 0.000 description 1
- 235000011449 Rosa Nutrition 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 description 1
- 244000173853 Sanguisorba officinalis Species 0.000 description 1
- 241001516602 Schlechtendalia chinensis Species 0.000 description 1
- 241000555745 Sciuridae Species 0.000 description 1
- 241001530126 Scrophularia Species 0.000 description 1
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 1
- 240000004534 Scutellaria baicalensis Species 0.000 description 1
- 206010041899 Stab wound Diseases 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000005844 Thymol Substances 0.000 description 1
- 241000219793 Trifolium Species 0.000 description 1
- 240000006917 Vernicia montana Species 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- WNFXUXZJJKTDOZ-HNNXBMFYSA-N [(1s)-1-(5,8-dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] acetate Chemical compound C1=CC(O)=C2C(=O)C([C@@H](OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-HNNXBMFYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 1
- MVNCAPSFBDBCGF-UHFFFAOYSA-N alpha-pinene Natural products CC1=CCC23C1CC2C3(C)C MVNCAPSFBDBCGF-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 239000000729 antidote Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 229940124575 antispasmodic agent Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 1
- 229960003321 baicalin Drugs 0.000 description 1
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WPVSVIXDXMNGGN-UHFFFAOYSA-N beta-bitter acid Natural products CC(C)CC(=O)C1=C(O)C(CC=C(C)C)(CC=C(C)C)C(=O)C(CC=C(C)C)=C1O WPVSVIXDXMNGGN-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000000013 bile duct Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- UHZZMRAGKVHANO-UHFFFAOYSA-M chlormequat chloride Chemical compound [Cl-].C[N+](C)(C)CCCl UHZZMRAGKVHANO-UHFFFAOYSA-M 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 1
- 229940117916 cinnamic aldehyde Drugs 0.000 description 1
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 1
- 235000017803 cinnamon Nutrition 0.000 description 1
- WJSDHUCWMSHDCR-VMPITWQZSA-N cinnamyl acetate Natural products CC(=O)OC\C=C\C1=CC=CC=C1 WJSDHUCWMSHDCR-VMPITWQZSA-N 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- KWGRBVOPPLSCSI-UHFFFAOYSA-N d-ephedrine Natural products CNC(C)C(O)C1=CC=CC=C1 KWGRBVOPPLSCSI-UHFFFAOYSA-N 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 210000005069 ears Anatomy 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 101150007166 ensa gene Proteins 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 230000002008 hemorrhagic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- VMSLCPKYRPDHLN-NRFANRHFSA-N humulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)[C@@](O)(CC=C(C)C)C1=O VMSLCPKYRPDHLN-NRFANRHFSA-N 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000004347 intestinal mucosa Anatomy 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 241000238565 lobster Species 0.000 description 1
- LSDULPZJLTZEFD-UHFFFAOYSA-N lupulone Chemical compound CC(C)CC(=O)C1=C(O)C(CC=C(C)C)=C(O)C(CC=C(C)C)(CC=C(C)C)C1=O LSDULPZJLTZEFD-UHFFFAOYSA-N 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 229940116852 myricetin Drugs 0.000 description 1
- PCOBUQBNVYZTBU-UHFFFAOYSA-N myricetin Natural products OC1=C(O)C(O)=CC(C=2OC3=CC(O)=C(O)C(O)=C3C(=O)C=2)=C1 PCOBUQBNVYZTBU-UHFFFAOYSA-N 0.000 description 1
- 235000007743 myricetin Nutrition 0.000 description 1
- DCYOADKBABEMIQ-OWMUPTOHSA-N myricitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=C(O)C=2)OC2=CC(O)=CC(O)=C2C1=O DCYOADKBABEMIQ-OWMUPTOHSA-N 0.000 description 1
- DCYOADKBABEMIQ-FLCVNNLFSA-N myricitrin Natural products O([C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](C)O1)C1=C(c2cc(O)c(O)c(O)c2)Oc2c(c(O)cc(O)c2)C1=O DCYOADKBABEMIQ-FLCVNNLFSA-N 0.000 description 1
- WSVWKHTVFGTTKJ-AWEZNQCLSA-N nantenine Chemical compound C1C2=CC=3OCOC=3C=C2C2=C(OC)C(OC)=CC3=C2[C@H]1N(C)CC3 WSVWKHTVFGTTKJ-AWEZNQCLSA-N 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 208000004995 necrotizing enterocolitis Diseases 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000010330 ougon Substances 0.000 description 1
- QUCQEUCGKKTEBI-UHFFFAOYSA-N palmatine Chemical compound COC1=CC=C2C=C(C3=C(C=C(C(=C3)OC)OC)CC3)[N+]3=CC2=C1OC QUCQEUCGKKTEBI-UHFFFAOYSA-N 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 201000006195 perinatal necrotizing enterocolitis Diseases 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- FFWOKTFYGVYKIR-UHFFFAOYSA-N physcion Chemical compound C1=C(C)C=C2C(=O)C3=CC(OC)=CC(O)=C3C(=O)C2=C1O FFWOKTFYGVYKIR-UHFFFAOYSA-N 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- KWGRBVOPPLSCSI-WCBMZHEXSA-N pseudoephedrine Chemical compound CN[C@@H](C)[C@@H](O)C1=CC=CC=C1 KWGRBVOPPLSCSI-WCBMZHEXSA-N 0.000 description 1
- 229940070687 psyllium Drugs 0.000 description 1
- 239000001057 purple pigment Substances 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- GRWFGVWFFZKLTI-UHFFFAOYSA-N rac-alpha-Pinene Natural products CC1=CCC2C(C)(C)C1C2 GRWFGVWFFZKLTI-UHFFFAOYSA-N 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- WNFXUXZJJKTDOZ-UHFFFAOYSA-N shikonin acetate Natural products C1=CC(O)=C2C(=O)C(C(OC(C)=O)CC=C(C)C)=CC(=O)C2=C1O WNFXUXZJJKTDOZ-UHFFFAOYSA-N 0.000 description 1
- NRHMKIHPTBHXPF-TUJRSCDTSA-M sodium cholate Chemical compound [Na+].C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC([O-])=O)C)[C@@]2(C)[C@@H](O)C1 NRHMKIHPTBHXPF-TUJRSCDTSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004071 soot Substances 0.000 description 1
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 150000005856 steroid saponins Chemical class 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960000790 thymol Drugs 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Description
【発明の詳細な説明】 [産業上の利用分野] 本発明は、家畜及び家禽のクロストリジウム パーフ
リンゲンス感染症の予防及び治療剤に関する。The present invention relates to an agent for preventing and treating Clostridium perfringens infection in livestock and poultry.
さらに詳しくは、本発明は生薬を主成分とする鶏、
豚、牛、羊のクロストリジウム パーフリンゲンス感染
症の予防及び治療剤に関する。More specifically, the present invention relates to a chicken comprising a crude drug as a main component,
The present invention relates to an agent for preventing and treating Clostridium perfringens infection in pigs, cattle, and sheep.
また本発明は、生薬を投与することからなる同感染症
の予防及び治療方法に関する。The present invention also relates to a method for preventing and treating the infectious disease comprising administering a crude drug.
[従来の技術] 家畜及び家禽のクロストリジウム パーフリンゲンス
感染症は、Clostridium perfringensの感染によって起
こる疾病で、代表的な症状として壊疽性腸炎があり、ま
たエンテロトキセミア、悪性水腫の原因にもなる。罹病
率、致死率がともに高く、養鶏、ブロイラー、養豚、酪
農業界に与える経済的被害は大きい。従って、家畜及び
家禽の数ある疾病の中でもその防除対策の確立が急がれ
る最も重要な疾病の1つである。[Background Art] Clostridium perfringens infection in livestock and poultry is a disease caused by infection with Clostridium perfringens, and has gangrene enteritis as a typical symptom, and also causes enterotoxemia and malignant edema. The morbidity and mortality are both high and the economic damage to the poultry, broiler, swine and dairy industries is significant. Therefore, it is one of the most important diseases for which the establishment of control measures is urgently required among a number of diseases of livestock and poultry.
壊疽性腸炎は、子豚、ヒナ等の疾病臨床的には下痢が
みられ、腸粘膜への細菌の侵入、小腸の壊死を伴うこと
を特徴とする。Necrotizing enterocolitis is characterized by diseases such as piglets and chicks, clinically showing diarrhea, invasion of bacteria into the intestinal mucosa, and necrosis of the small intestine.
エンテロトキセミアは、クロストリジウム パーフリ
ンゲンスが動物の小腸内で増殖し、その産生する毒素に
より、壊死性、出血性の病変を起こし、かつ毒血症のた
めに急性死を招く疾病である。Enterotoxemia is a disease in which Clostridium perfringens proliferates in the small intestine of animals, produces necrotic, hemorrhagic lesions due to toxins produced, and causes acute death due to toxicemia.
悪性水腫は、偶発的または外科手術により生じた創面
に、菌が侵入して発生し、その菌が発芽、増殖して毒素
を出し、毒血症、菌血症を起こし死に至らせる疾病であ
る。Malignant edema is a disease that is caused by the invasion of bacteria into the wound surface created by accident or surgery, which germinates, proliferates, emits toxins, causes toxicemia, bacteremia, and death. .
このように、クロストリジウム パーフリンゲンス感
染症は、重大な伝染病であるにもかかわらず、予防・治
療方法が未だ確立されていない。Thus, despite the fact that Clostridium perfringens infection is a serious infectious disease, no preventive or therapeutic method has yet been established.
予防方法として、飼育管理を適当に行なうことなどが
行なわれているが、実際には予防は極めて困難である。As a preventive method, breeding management is appropriately performed. However, in practice, prevention is extremely difficult.
また、これまでに本症を予防及び治療するために、抗
生物質やその他の抗菌剤を飼料とともに投与する方法も
行なわれている。しかし、近年、特に耐性菌の発生や食
肉への抗生物質等の残留性の問題などがあって、抗生物
質などの投与を動物に対して行なうことは適当ではない
という気運が高まりつつある。従って、抗生物質などを
用いない本症の予防及び治療方法と予防及び治療剤の開
発が望まれている。In addition, a method of administering an antibiotic or other antibacterial agent together with feed to prevent and treat the disease has been used. However, in recent years, there is a growing tendency that it is not appropriate to administer antibiotics and the like to animals due to the occurrence of resistant bacteria and the persistence of antibiotics and the like in meat. Therefore, development of a method for preventing and treating this disease without using an antibiotic or the like and an agent for preventing and treating the disease are desired.
[問題点を解決するための手段] 本発明者らは、上記の問題点を解決すべく研究した結
果、ある種の生薬に本疾病を抑制する効果がある事を見
出し、本発明を完成させた。[Means for Solving the Problems] The present inventors have conducted studies to solve the above problems, and as a result, have found that certain crude drugs have an effect of suppressing the disease, and completed the present invention. Was.
即ち、本発明の目的は、家畜及び家禽のクロストリジ
ウム パーフリンゲンス感染症の予防及び治療剤並びに
同症の予防及び治療方法を提供することにある。That is, an object of the present invention is to provide an agent for preventing and treating Clostridium perfringens infection in livestock and poultry, and a method for preventing and treating the same.
本発明は、カンゾウ、ヨモギ、オウレン、オウゴン、
オウバク、ゲンノショウコ、コウボク、タンジン、チ
モ、ダイオウ、チョウジ、ジョテイ、ケイガイ、ケイ
ヒ、ゲンジン、ケツメイシ、ビワヨウ、ボウフウ、ホッ
プ、ソヨウ、ヨウバイヒ、レンギョウ、アロエ、ギョウ
タン、イレイセン、ウバイ、エンメイソウ、シャゼンソ
ウ、シンイ、インチンコウ、ジンコウ、センキュウ、コ
ウホン、ゴバイシ、サンシュユ、シコン、コオウレン、
シャクヤク、キンオウシ、タイム、シロナンテン、チユ
及びマオウからなる群から選択された1種または2種以
上の生薬を含有する家畜及び家禽のクロストリジウム
パーフリンゲンス感染症の予防及び治療剤を提供するも
のである。The present invention relates to licorice, mugwort, spinach, orchid,
Obak, Gennoshoko, Koboku, Tanjin, Chimo, Daio, Coji, Jotei, Keikai, Keihi, Genjin, Ketsumeishi, Biwayou, Bowhu, Hop, Soyou, Iowaihi, Forsythia, Aloe, Gourd, Ireisen, Ubai, Emmaiso, Shazensou Clinch, Jinko, Senkyu, Kouhon, Gobishi, Sanshuyu, Sicon, Kouren,
Clostridium of livestock and poultry containing one or more crude drugs selected from the group consisting of peonies, bullfinch, thyme, shironanthene, chiyu and ephedra
It is intended to provide an agent for preventing and treating perfringens infection.
本発明はまた原末の形態の生薬、有機溶剤、有機溶剤
と水との混合物または水で抽出して得られる生薬エキ
ス、または生薬有効成分を含有する家畜及び家禽の同疾
病の予防及び治療剤を提供するものである。The present invention also provides a crude drug in an original form, an organic solvent, a mixture of an organic solvent and water or a crude drug extract obtained by extraction with water, or a preventive and therapeutic agent for the same disease in livestock and poultry containing a crude drug active ingredient. Is provided.
さらに本発明は、カンゾウ、ヨモギ、オウレン、オウ
ゴン、オウバク、ゲンノショウコ、コウボク、タンジ
ン、チモ、ダイオウ、チョウジ、ジョテイ、ケイガイ、
ケイヒ、ゲンジン、ケツメイシ、ビワヨウ、ボウフウ、
ホップ、ソヨウ、ヨウバイヒ、レンギョウ、アロエ、ギ
ョウタン、イレイセン、ウバイ、エンメイソウ、シャゼ
ンソウ、シンイ、インチンコウ、ジンコウ、センキュ
ウ、コウホン、ゴバイシ、サンシュユ、シコン、コオウ
レン、シャクヤク、キンオウシ、タイム、シロナンテ
ン、チユ及びマオウからなる群から選択された1種また
は2種以上の生薬の有効量を投与することからなる家畜
及び家禽の同疾病の予防及び治療方法を提供するもので
ある。Further, the present invention provides liquorice, mugwort, spinach, ogre, oak, gennoshoko, kouboku, tanjin, timo, rhubarb, clove, jotei, kayai,
Keihi, Genjin, Ketsumeishi, Biwayou, Boufu,
Hop, soybean, biloba, forsythia, aloe, gourd, irisen, squid, emmeisou, shazensou, shinii, inchinko, ginko, senkyu, kohon, gobishi, sanshuyu, sicon, squirrel, peonies, quinoushi, thyme, shironanten, and shironanten It is intended to provide a method for preventing and treating the disease in livestock and poultry, comprising administering an effective amount of one or more crude drugs selected from the group consisting of:
本発明はまた、原末の形態の生薬、有機溶剤、有機溶
剤と水との混合物または水で抽出して得られる生薬エキ
ス、または生薬有効成分の形態で投与することからなる
哺乳類の同疾病の予防及び治療方法を提供するものであ
る。The present invention also provides a crude drug in the form of a bulk powder, an organic solvent, a mixture of an organic solvent and water or a crude drug extract obtained by extraction with water, or a herbal medicine comprising administering the same in the form of a crude drug active ingredient. It provides a method for prevention and treatment.
本発明はまた、生薬を、飼料中に配合して投与するこ
とからなる家畜及び家禽の同疾病の予防及び治療方法を
提供するものである。The present invention also provides a method for preventing and treating the same disease in livestock and poultry, which comprises administering a crude drug in a feed.
カンゾウ(甘草)は、カンゾウ(Glycyrrhizaglabra
Linne′ var.glandulifera Regel et Herder)の根お
よび根茎をそのまま、またはコルク皮を除いたものであ
る。このものは成分としてグリシルリチン、リキリチ
ン、ブドウ糖、アスパラギン等を含み、ヒトの緩和、鎮
痙薬、 として用いられている。Licorice (Glycyrrhizaglabra)
Linne 'var. Glandulifera Regel et Herder) roots and rhizomes as such or without cork skin. It contains glycyrrhizin, liquiritin, glucose, asparagine, etc. as ingredients, relieves humans, antispasmodics, It is used as
ヨモギ(艾)は、ヨモギ(Artemisia princeps Pampa
nini)またはヤマヨモギ(A.montana Pampanini)の葉
である。このものは成分として、シネオール(50%)の
他、α−ツヨン、セスキテルペン等を含む精油やアルカ
ロイドを含み、ヒトの収れん及び止血薬として子宮出血
等に用い、強壮、補血の効果もある。Artemisia princeps Pampa
nini) or sagebrush (A. montana Pampanini) leaves. It contains essential oils and alkaloids including α-thuyon, sesquiterpene, etc. in addition to cineol (50%) as a component, and is used for uterine bleeding and the like as an astringent and hemostatic agent for humans, and has tonic and blood-supplying effects.
オウレン(黄連)は、オウレン(Coptis japonica Ma
kino)の根茎から細根を焼去ったものである。このもの
は成分として、ベルベリン、パリマチン等を含み、ヒト
の健胃苦味、整腸薬として用いられている。Spinach (Yellow) is spinach (Coptis japonica Ma)
Fine roots are burned off from the roots of kino). It contains berberine, parimatin and the like as components, and is used as a stomach stomach bitter in humans and an intestinal medicine.
オウゴン は、コガネバナ(Scutellaria baicalensis Georgi)の
コルク皮を除いた根である。このものは成分として、オ
ーゴニンとバイカリンを含み、ヒトの消炎、解熱薬とし
て用いられている。Ougon Is the root of Scutellaria baicalensis Georgi excluding the cork skin. It contains agonine and baicalin as components and is used as a human anti-inflammatory and antipyretic drug.
オウバク(黄柏)は、キハダ(Phellodendronamurens
e Ruprecht)またはその他の同属他種植物の樹皮のコル
ク層を除いたものである。このものは成分として、ベル
ベリン、パルマチン等を含み、ヒトの健胃、整腸、収れ
ん及び消炎薬として用いられている。Yellowtail (Phellodendronamurens)
e Ruprecht) or other congeners or other species of bark without the cork layer. It contains berberine, palmatin and the like as components, and is used as a stomachic, intestinal astringent, astringent and anti-inflammatory drug for humans.
ゲンノショウコは、ゲンノショウコ(Geraniumnepale
nse Sweet)の夏期の茎葉である。このものは成分し
て、タンニン、没食子酸、コハク酸等を含み、ヒトの収
れん薬として下痢、腹痛に用いられる。Gennoshoko, Geraniumnepale
nse Sweet). It contains tannin, gallic acid, succinic acid, etc. as components and is used as astringent drug for humans for diarrhea and abdominal pain.
コウボク(厚朴)は、ホオノキ(Magnoliaobovata Th
unberg)の樹及び枝の皮である。このものは成分とし
て、主成分をマチロール、マグノロールとする精油やマ
グノクマリン等を含み、ヒトの収れん性利尿、 として胸腹部の膨満、腹痛及び喘咳に用いられている。Koboku (Magnolia), Magnoliaobovata Th
unberg) trees and branches. This product contains, as an ingredient, essential oils such as methylol and magnolol, essential oils and magnocoumarins, and human astringent diuresis. It is used for chest and abdominal distension, abdominal pain and asthma.
タンジン(丹参)はタンジン(Salvia miltiorrhiza
Bunge)の根である。このものは成分として、タンジノ
ンI,II、クリプトタンジノンを含み、ヒトの強壮、通
経、婦人薬として月経不調、子宮出血、腹痛及び諸瘡に
用いられる。Tanjin (Salvia miltiorrhiza)
Bunge). It contains tandinone I, II and cryptotandinone as ingredients and is used for tonicity, menstruation, menstrual disorders, uterine bleeding, abdominal pain and acne as a feminine drug.
チモ(知母)は、ハナスゲ(Anemanhenaasphodeloide
s Bunge)の根茎である。このものは成分としてサポニ
ン、ステロイドサポニン、タンニン等を含み、ヒトの消
炎、解熱、止瀉、利尿、鎮痛薬として用いられている。Chimo (Chimo) is a sedge (Anemanhenaasphodeloide)
s Bunge) rhizome. It contains saponin, steroid saponin, tannin and the like as components and is used as an anti-inflammatory, antipyretic, antidiarrheal, diuretic, and analgesic in humans.
ダイオウ(大黄)は、ダイオウ(Rheumpalmatum Linn
e′またはR.officinale Baillon)及び近縁植物の根茎
の皮部をほとんど除去して縦割したものである。このも
のは成分として、アントラキノン誘導体としてのクリソ
ファノール、エモジン、エモジンモノメチルエーテル等
を含み、ヒトの健胃苦味、緩下、消炎薬として慢性胃腸
病、消化不良、便秘症に用いられている。Rhubarb (Rhuang) is a rhubarb (Rheumpalmatum Linn)
e ′ or R. officinale Baillon) and the relatives of the rhizomes of the rhizomes were almost completely removed and vertically divided. It contains chrysophanol, emodin, emodin monomethyl ether, etc. as anthraquinone derivatives as components, and is used for human gastric stomach bitterness, laxity, and as an anti-inflammatory drug for chronic gastrointestinal diseases, dyspepsia, and constipation. .
チョウジ(丁子)は、チョウジ(Eugeniacaryophylla
ta Thunb.)の開花直前のつぼみである。このものは成
分として、オイゲノール、アセチルオイゲノール等を含
み、ヒトの消化機能促進、駆虫薬として、また香辛料、
化粧品としても用いられている。The butterfly (clove) is a butterfly (Eugeniacaryophylla)
ta Thunb.) just before flowering. It contains eugenol, acetyl eugenol, etc. as ingredients, promotes human digestive function, as an anthelmintic, and spices,
It is also used as cosmetics.
ジョテイ(女貞)は、ネズミモチ(Ligustrum japoni
cum Thunberg)の果実である。このものは成分として、
オレアノール酸、ブドウ糖等を含み、ヒト強壮薬として
用いられている。Jotei (Virgin) is a rat rodent (Ligustrum japoni)
cum Thunberg). This is an ingredient
Contains oleanolic acid, glucose, etc. and is used as a human tonic.
ケイガイ(荊芥)は、ケイガイ(Nepeta japonica Ma
ximowicz)の花期の地上部で通例長さ3〜5mmの切片で
ある。このものは成分としてd−メントン、d−リモネ
ン等を含み、ヒトの発汗、解熱、解毒薬として用いられ
る。Kaigai (Negeta japonica Ma)
ximowicz) is a section of 3-5 mm long, usually in the aerial part of the flower stage. It contains d-menthon, d-limonene, and the like as components and is used as a human antiperspirant, antipyretic and antidote.
ケイヒ(桂皮)は、ケイジュ(Cinna momum Cassia B
lume)の乾皮及び桂皮を剥ぎコルク層を多少除いたもの
である。このものは成分として、シンナムアルデヒド、
酢酸シンナミル等を含み、ヒトの発汗、解熱、鎮痛、健
胃、整腸、駆虫薬として用いられている。Cahi (Cinnamon bark) is Cage (Cinna momum Cassia B)
lume) is obtained by removing the dry skin and cinnamon bark and removing some of the cork layer. It has cinnamaldehyde,
It contains cinnamyl acetate and the like and is used as sweating, antipyretic, analgesic, stomachic, intestinal and anthelmintic in humans.
ゲンジン(玄参)は、ゴマノハグサ(Scrophularia O
ldhami Oliver)の根である。ヒトの消炎、解熱、鎮痛
及び性病薬として用いられている。Genzine is a Scrophularia O
ldhami Oliver). It is used as an anti-inflammatory, antipyretic, analgesic and venereal agent in humans.
ケツメイシ(決明子)は、エビスグサ(Cassiaobtusi
folia Linne′)の成熟した種子である。このものは成
分として、エモジン、オブツシフオリン等を含み、俗に
ハブ茶と呼ばれ飲料として茶に代用される。Ketsumeishi (Keishiko) is a Japanese lobster (Cassiaobtusi)
folia Linne '). It contains emodin, obtusifuolin and the like as components, and is commonly called hub tea and is substituted for tea as a beverage.
ビワヨウ(枇杷葉)は、ビワ(Eriobotrya japonica
Lindley)の葉の軟毛をできるだけ除いたものである。
このものはブドウ糖、ショ糖、果糖、マルトース等を成
分として含み、ヒトの清涼、健胃薬として暑気あたりや
その予防薬として用いられていたものである。Loquat (loquat leaf) is loquat (Eriobotrya japonica)
Lindley) leaves are removed as much as possible.
It contains glucose, sucrose, fructose, maltose, and the like as components, and has been used as a cool and stomach medicine for humans and as a preventive for hot weather.
ボウフウ(防風)は、イブキボウフウ(Seselilibano
tis Koch var.daucifolia DC.)の根を根茎とともに乾
燥したものである。このものは成分として、精油を含有
し、ヒトの発汗、解熱、鎮痛薬として風邪で頭痛、悪
寒、関節痛を伴う場合に用いられている。Bofu (Windbreak) is Ibukibofu (Seselilibano)
tis Koch var. daucifolia DC.) together with rhizomes. It contains essential oil as an ingredient, and is used as a sweating, antipyretic and analgesic in humans with headache, chills and joint pain due to colds.
ホップは、ホップ(Humulus Lupulus Linne′)の
成熟した果穂である。このものは成分として、タンニ
ン、フムロン、ルプロン等を含み、ビールの醸造におい
て、苦味および芳香を附けるために必要なものである。Hops are mature ears of hops (Humulus Lupulus Linne '). It contains tannin, humulone, lupulon and the like as components and is necessary for imparting bitterness and aroma in beer brewing.
ソヨウ(蘇葉)は、シソ(Perilla frutescens Britt
on var.acuta Kudo)の葉である。このものは成分とし
て0.5〜1%の精油を含み、その55%がペリラアルデヒ
ドで、その他リモネン、α−ピネン等も含む。ヒトの興
奮性発汗、解熱、鎮咳、鎮痛、鎮静、利尿、健胃薬等と
して用いられる。Soybean (Soyo) is perilla (Perilla frutescens Britt)
on var.acuta Kudo). It contains 0.5-1% essential oil as a component, 55% of which is perilaldehyde, and also contains limonene, α-pinene and the like. It is used as excitable sweating, antipyretic, coughing, analgesic, sedative, diuretic, stomachic and the like in humans.
ヨウバイヒ(揚梅皮)は、ヤマモモ(Myricarubra Si
ebold et Zuccarini)の樹皮である。このものは成分と
して、タンニン、ミリセチン及びミリシトリン等を含
み、ヒトの収れん薬として下痢に用い、また打撲症にも
効果がある。Bayberry (fried plum skin), bayberry (Myricarubra Si
ebold et Zuccarini). It contains tannin, myricetin, myricitrin, etc. as components, is used as astringent drug for humans for diarrhea, and is also effective for bruises.
レンギョウ(連翹)は、レンギョウ(Forsythia susp
ensa Vahl)またはチョウセンレンギョウ(F.koreanum
Ohwi)の果実である。このものは成分としてオレアノー
ル酸等を含み、ヒトの解毒、排膿、消炎、利尿薬として
用いられている。Forsythia (Forsythia susp)
ensa Vahl) or Datura (F.koreanum)
Ohwi) fruit. It contains oleanolic acid as a component and is used as a detoxification, drainage, anti-inflammatory and diuretic in humans.
アロエは、アロエ(Aloe arborescens Mill.var.nata
lensis Bergel.)の粘液を煮つめたものである。このも
のは成分として、バルバロイン、アロエ−エモジン等を
含み、中東やヨーロッパで非常に古くからヒトの苦味健
胃薬または下剤として用いられている。Aloe is aloe (Aloe arborescens Mill.var.nata
lensis Bergel.) It contains barbaloin, aloe-emodin, etc. as components and has been used as a human bitter stomachic or laxative for a long time in the Middle East and Europe.
ギュウタン(牛胆)は、ウシ(Bostaurusdomesticus
Gmelin)の胆のうをぶら下げて陰干しするか、または胆
管を切開して胆汁を容器に入れて密封貯蔵したものであ
る。このものは成分として、コール酸ナトリウム塩、ム
コタンパク質、脂肪酸等を含み、ヒトの黄疽、便秘、糖
尿病、痔瘡等の治療に古くから用いられている。Gyutan (cow bile) is a cow (Bostaurusdomesticus)
Gmelin) can be obtained by hanging the gall bladder in the shade or by incising the bile duct and storing the bile in a sealed container. It contains, as an ingredient, sodium cholate, mucoprotein, fatty acids and the like, and has been used for a long time for the treatment of human jaundice, constipation, diabetes, hemorrhoids and the like.
イレイセン(威霊仙)は、テッセン(Clematis Maxim
owicziana Franchet et Savatier var.forida Thunber
g)または同属近縁植物の根である。このものは成分と
してサポニンを含み、ヒトの利尿及び鎮痛薬として、痛
風、リウマチス及び神経痛に用いられる。Irene (Celeme)
owicziana Franchet et Savatier var.forida Thunber
g) or a root of a closely related plant of the same genus. It contains saponin as an ingredient and is used for gout, rheumatism and neuralgia as a human diuretic and analgesic.
ウバイ(烏梅)は、ウメ(Prunus Mume Siebold et Z
uccarini)の未熟の果実から果皮を剥いで煤煙中に埋め
て乾燥したものである。このものの成分は、コハク酸、
クエン酸、リンゴ酸、酒石酸等であり、ヒトの清涼性収
れん薬、止瀉、蛔虫駆除、解熱薬等として用いられる。Ubai (Plumus Mume Siebold et Z)
The fruit is peeled from the immature fruit of uccarini), buried in soot and dried. The ingredients for this are succinic acid,
Citric acid, malic acid, tartaric acid and the like are used as a refreshing astringent for humans, antidiarrheal, exterminating Ascaris, and antipyretic.
エンメイソウ(延命草)は、ヒキオコシ(Isodon jap
onica Hara)またはクロバナヒキオコシ(Isodon trich
ocarpus Kudo)の茎葉である。このものは成分として、
プレクトランチン及びエンメインを含み、ヒトの健胃苦
味薬として消化不良、食欲不振、腹痛等の治療に用いら
れる。Enmeiso (extended lifegrass) is a cypress (Isodon jap)
onica Hara) or black clover (Isodon trich)
ocarpus Kudo). This is an ingredient
It contains Plectrantin and Emmain, and is used as a stomach bitter medicine in humans for the treatment of indigestion, anorexia, abdominal pain and the like.
シャゼンソウ(車前草)は、オウバコ(Plantage asi
atica Linne′)の花期の全草である。このものは成分
として、アウクビン、プランタギニン等を含み、消炎、
利尿薬としてヒトの眼疾、膀胱炎等に用いられている。Shazensou (vegetative grass) is a psyllium (Plantage asi
atica Linne '). It contains, as an ingredient, aukbin, plantaginine, etc.
It is used as a diuretic for human eye diseases, cystitis and the like.
シンイ(辛夷)は、コブシ(Magnolia Kobus A.P.De
Candolle)のツボミである。このものは成分として、シ
トラール、オイゲノール、シネオール等を含み、芳香薬
でヒトの頭痛、瘡毒、鼻疾等に用いられる。Shin Yi, Kobushi (Magnolia Kobus APDe)
It is the bud of Candolle). It contains citral, eugenol, cineol and the like as ingredients and is used as a fragrance for human headache, venom and nasal diseases.
インチンコウ は、カワラヨモギ(Artemisia capillaris Thunberg)
の花穂である。このものは成分としてカピレン、β−ピ
ペン、カピロン、カピリンなどのテルペン化合物やイン
クマリン体のカピラリン等を含み、ヒトの消炎、解熱、
利尿薬として発熱性の黄疽に有効である。Clapperboard The Artemisia capillaris Thunberg
This is the spike. This product contains terpene compounds such as capylene, β-pipen, capilone, and capillin as well as capillarin in the incmarine body.
It is effective as a diuretic for febrile jaundice.
ジンコウ(沈香)は、ジンコウ(Aquilariaagallocha
Roxb.)の樹脂を含んだ木材である。このものは成分と
して、ベンジルアセトン、p−メトキシベンジルアセト
ン、ヒドロケイ皮酸等を含み、香木として「香道」の主
役をなす材料とされる。また薬用としては一種の鎮静作
用、疲労回復作用を期待して、喘咳、嘔吐、腹痛等に用
いられる。Jingko (Agaric) is a Jingko (Aquilariaagallocha)
Roxb.) Containing wood. This material contains benzylacetone, p-methoxybenzylacetone, hydrocinnamic acid, and the like as components, and is a material that plays the main role of "Kodo" as a perfume. As a medicament, it is used for asthma, vomiting, abdominal pain, etc., with the expectation of a kind of sedative action and fatigue recovery action.
センキュウ は、センキュウ(Cnidium officinale Makino)の根を
除いた根茎を通例湯通しして乾燥したものである。この
ものは成分としてクニジウムラクトン、クニジウム酸等
を含み、ヒトの浄血、補血、強壮及び鎮静薬として貧血
症、冷え症、月経不順等に用いられている。Sengkyu Is a rhizome excluding the root of Cecium officinale Makino, which is usually blanched and dried. It contains kunidinium lactone, kunidiic acid and the like as components and is used as a blood purifying, blood-supplying, tonic and sedative for humans such as anemia, chills and irregular menstruation.
コウホン(藁本)は、カサモチ(Nothosmyrnium japo
niccum Miquel)の根茎である。このものは成分とし
て、ノトスミルノール、ジメトキシアリルベンゼンを主
成分とする精油を含有し、ヒトの鎮痙、鎮痛薬として用
いられている。Kouhon (straw) is a crustacean (Nothosmyrnium japo
niccum Miquel) rhizome. It contains essential oils containing notosmyrnol and dimethoxyallylbenzene as main components, and is used as an antispasmodic and analgesic for humans.
ゴバイシ(五倍子)は、ヌルデノミミフシアブラムシ
(Melaphis chinensis J.Bell)の刺傷により主として
ヌルデ(Rhus javanica Linne′)の葉に生じたゴール
であって、成分としてタンニン、没食子酸、脂肪、樹脂
等を含む。五倍子チンキ、タンニン酸、没食子酸、ピロ
ガロールの製造原料とされる。Gobishi is a goal mainly formed on the leaves of nurde (Rhus javanica Linne ') due to a stab wound of a nuldenomifushibashimushi (Melaphis chinensis J. Bell). Including. It is used as a raw material for producing quintuple tincture, tannic acid, gallic acid, and pyrogallol.
サンシュユ(三茱萸)は、サンシュユ(Cornus offic
inalis Siebold et Zuccarini)の成熟した果実から種
子を抽いたものである。このものは成分として結晶性の
有機酸、没食子酸、リンゴ酸、酒石酸等を含み、ヒトの
滋養、強壮、収れん薬として用いられている。Sanshuyu (Sanshuyu), Sanshuyu (Cornus offic)
inalis Siebold et Zuccarini). It contains crystalline organic acids, gallic acid, malic acid, tartaric acid and the like as components and is used as a nourishing, tonic and astringent drug for humans.
シコン(紫根)は、ムラサキ(Lithospermum officin
ale Linne′ var.erythrorhizon Maximowicz)の根であ
る。このものは成分として紫色素アセチルシコニン等を
含み、ヒトの解熟、解毒薬として用いられている。Shikon (purple root) is purple (Lithospermum officin)
ale Linne 'var.erythrorhizon Maximowicz). It contains a purple pigment acetyl shikonin as a component and is used as a detoxifying and detoxifying agent for humans.
コオウレン(胡黄連)は、コオウレン(Picrorrhiza
Kurooa Royle ex Benth.)の根茎である。このものは成
分として、クトキン、D−マンニトール、バニリン酸等
を含み、ヒトの苦味健胃、緩下剤として用いられてい
る。Kouren (Hou Lian) is the cricket (Picrorrhiza)
It is the rhizome of Kurooa Royle ex Benth.). It contains cutin, D-mannitol, vanillic acid and the like as components and is used as a human bitter stomach and laxative.
シャクヤク(芍薬)は、シャクヤク(Paeonia albifl
ora Pallas var.trichocarpa Bunge)の根である。成分
として安息香酸、樹脂等を含み、ヒトの収れん、緩和、
鎮痛、鎮痙薬として用いられている。Peony (peony) is a peony (Paeonia albifl)
ora Pallas var.trichocarpa Bunge). Contains benzoic acid, resin, etc. as ingredients, astringent, relaxing,
It is used as an analgesic and antispasmodic.
キンオウシ(金桜子)は、ナニワイバラ(Rosa Laevi
gata Michaux)の偽果である。このものは成分として、
クエン酸、リンゴ酸、タンニン、サポニン、ビタミンC
等を含み、ヒトの下痢や多尿を止めるのに用いられてい
る。Kinu Oshi (Kanekurako) is a Nani Waibara (Rosa Laevi)
gata Michaux). This is an ingredient
Citric acid, malic acid, tannin, saponin, vitamin C
It is used to stop human diarrhea and polyuria.
タイムは、タチジャコソウ(Thymus vulgaris Linn
e′)の花期の全草である。このものは成分として、チ
モール、パラシモール、ピネン等を含み、ヒトの鎮咳薬
としてその煎剤またはエキスが用いられている。また食
品に防腐剤を兼ねた賦香料として用いられる。Thyme is Thymus vulgaris Linn
e ′) It is the whole plant in the flowering season. It contains thymol, parasimole, pinene and the like as components, and its decoction or extract is used as a human antitussive. It is also used in foods as a flavoring agent that also serves as a preservative.
シロナンテン(白南天)は、Nandina domestica Thun
b.var.leucocarpa Makinoの果実を乾燥したものであ
る。このものは成分として、ドメスチン、プロトピン
(アルカロイド)等を含み、ヒトの喘息、百日咳などに
鎮咳薬として用いられている。Shironanthen is Nandina domestica Thun
b.var.leucocarpa Makino fruit is dried. It contains domestine, protopin (alkaloid) and the like as components and is used as an antitussive for human asthma, pertussis and the like.
チユ(地楡)は、ワレモコウ(Sanguisorba officina
lis L.)の根部を採り、乾燥したものである。このもの
は成分として、タンニン(17%)、サポニンを含み、ヒ
トの止血収れん薬として、吐血、喀血、月経過多に用い
られる。Chiyu (Jiyu) is a waremokou (Sanguisorba officina)
lis L.) and dried. It contains tannin (17%) and saponin as components, and is used as a hemostatic astringent in humans for hematemesis, hemoptysis, and menorrhagia.
マオウ(麻黄)は、マオウ(Ephedra sinica Stapf)
の地上茎である。このものは成分として、l−エフェド
リン、d−シュードエフェドリン等を含み、ヒトの鎮
咳、発汗、利尿薬として用いられている。Ephedra (Ephedra) is Ephedra (Ephedra sinica Stapf)
Above ground stem. It contains l-ephedrine, d-pseudoephedrine and the like as components and is used as an antitussive, sweating and diuretic in humans.
上記したように、本発明で用いる生薬のカンゾウ、ヨ
モギ、オウレン、オウゴン、オウバク、ゲンノショウ
コ、コウボク、タンジン、チモ、ダイオウ、チョウジ、
ジョテイ、ケイガイ、ケイヒ、ゲンジン、ケツメイシ、
ビワヨウ、ボウフウ、ホップ、ソヨウ、ヨウバイヒ、レ
ンギョウ、アロエ、ギョウタン、イレイセン、ウバイ、
エンメイソウ、シャゼンソウ、シンイ、インチンコウ、
ジンコウ、センキュウ、コウホン、ゴバイシ、サンシュ
ユ、シコン、コオウレン、シャクヤク、キンオウシ、タ
イム、シロナンテン、チユ及びマオウの夫々は、それら
を単独でか、または組合わせてヒトの疾病の予防及び治
療のために従来から使用されていたものであるが、これ
らを動物の疾病の予防及び治療の目的、殊に動物の感染
症の予防及び治療の目的で使用する試みはこれまでにな
されたことがなかった。As described above, the crude drugs used in the present invention, liquorice, mugwort, spinach, giant gourd, oubaku, genoshoko, kouboku, tanjin, timo, rhubarb, clove,
Jotei, Keigai, Keihi, Genjin, Ketsumeishi,
Loquat, boufu, hop, soybean, lobster, forsythia, aloe, gourd, irisen, ubai,
Emmeso, Shazenso, Shiny, Inchinko,
Each of Jinko, Senkyu, Kohon, Gobishi, Sanshuyu, Sikon, Koouren, Peony, Kinuushi, Thyme, Shironanten, Chiyu and Ephedra, each alone or in combination, has been used for the prevention and treatment of human diseases. However, no attempt has been made to use them for the purpose of preventing and treating animal diseases, in particular, for preventing and treating animal infectious diseases.
本発明者らは上記した生薬の薬効に着目して種々研究
を行なった結果、クロストリジウムパーフリンゲンス感
染症、即ち家畜及び家禽がClostridium perfringensに
感染することによって発生する疾病の予防及び治療に上
記した生薬の1種または2種以上を組合わせて投与する
ことがきわめて有効であることを見出し、本発明を完成
したのである。The present inventors have conducted various studies focusing on the medicinal effects of the crude drugs described above, and as a result, described above in the prevention and treatment of Clostridium perfringens infection, that is, a disease caused by infection of livestock and poultry with Clostridium perfringens. The present inventors have found that it is extremely effective to administer one or more crude drugs in combination, and have completed the present invention.
即ち、下記するように、上記した特定の種類の生薬及
びその抽出物が、インビトロ及びインビボにおいて細菌
Clostridium perfringensに対し特異的に静菌作用及び
殺菌作用があることが明らかになった。そしてこのClos
tridium perfringensに対する抑制効果の結果、上記し
た生薬を豚に投与した場合にClostridium perfringens
に由来する家畜及び家禽の疾病であるクロストリジウム
感染症を予防及び治癒することができたのである。That is, as described below, the above-mentioned specific types of crude drugs and their extracts can
Clostridium perfringens was found to have a specific bacteriostatic and bactericidal action. And this Clos
As a result of the inhibitory effect on tridium perfringens, Clostridium perfringens
Thus, it was possible to prevent and cure clostridial infection, which is a disease of livestock and poultry originating from the country.
そしてこの家畜及び家禽に特有の疾病に対して上記し
た特定のこれら生薬及びその抽出物が有効であることは
予想もしえなかったことで、本発明者らによってはじめ
て明らかにされたことである。The fact that these specific herbal medicines and extracts thereof are effective against the diseases specific to livestock and poultry was unexpected and was first revealed by the present inventors.
これら生薬は原末そのまま、または抽出エキス、生薬
有効成分の形態で直接投与したり、またこれらのものを
飼料に添加したりあるいは溶液製剤、分散製剤、半固形
製剤、粉粒体製剤、成型製剤、浸出製剤、注射用製剤等
に製剤化して使用する。These crude drugs may be directly administered as raw powder or in the form of an extract or crude drug active ingredient, or they may be added to feed or in the form of a solution, dispersion, semi-solid, powder, granule, or molded product. , Leaching preparations, injection preparations and the like.
抽出エキスは、例えば水、有機溶剤または水と有機溶
剤との混合物を使用して溶剤抽出し、それをそのまま
か、濃縮してか、希釈してか、または溶剤を除去して用
いられる。The extraction extract is used, for example, by solvent extraction using water, an organic solvent or a mixture of water and an organic solvent, and then directly extracting, concentrating, diluting, or removing the solvent.
有機溶剤としては、例えばメタノール、エタノール、
n−プロパノール、n−ブタノール、アセトン、酢酸エ
チル、エーテル、塩化メチレン、クロロホルム、ベンゼ
ン、四塩化炭素、石油エーテル等が使用され、特にメタ
ノール、エタノールが望ましい。これらの有機溶剤は1
種または2種以上の混合物として用いることができる。As the organic solvent, for example, methanol, ethanol,
n-Propanol, n-butanol, acetone, ethyl acetate, ether, methylene chloride, chloroform, benzene, carbon tetrachloride, petroleum ether and the like are used, and methanol and ethanol are particularly desirable. These organic solvents are 1
It can be used as a species or a mixture of two or more species.
この溶剤抽出は、生薬をこれらの溶剤に冷浸または温
浸して行なうことができる。冷浸の場合には15℃〜25
℃、温浸の場合は35〜45℃の温度範囲で行なうことがで
きる。抽出時間は、抽出温度によって異なるが、一般的
には約5日間または可溶性成分が充分に溶けるまでとす
る。This solvent extraction can be performed by cold or hot digestion of the crude drug in these solvents. 15 ℃ ~ 25 for cold immersion
C. and in the case of digestion, it can be carried out in a temperature range of 35 to 45.degree. The extraction time depends on the extraction temperature, but is generally about 5 days or until the soluble components are sufficiently dissolved.
生薬有効成分は、例えば、上記抽出エキスをさらに各
種溶剤を用いて振盪し、この溶剤に移行する画分を採り
出し、その溶剤を留去したものを有効画分、即ち有効成
分として用いることもできる。Crude drug active ingredient, for example, the extract extract is further shaken using various solvents, a fraction that is transferred to this solvent is extracted, and the solvent is distilled off, and the effective fraction, that is, the active ingredient may be used as the active ingredient. it can.
この場合に使用される溶剤は、非極性溶剤例えば、低
級脂肪族エーテル類(ジエチルエーテル、エチルメチル
エーテル等);低級ハロゲンアルカン類、(クロロホル
ム、ジクロルエタン、ジブロモエタン等);ベンゼン類
(ベンゼン、トルエン、キシレン等);その他の石油系
溶剤(石油エーテル、石油ベンゼン、リグロイン等)等
が例としてあげられる。Solvents used in this case are non-polar solvents such as lower aliphatic ethers (diethyl ether, ethyl methyl ether, etc.); lower halogen alkanes (chloroform, dichloroethane, dibromoethane, etc.); benzenes (benzene, toluene , Xylene, etc.); and other petroleum solvents (petroleum ether, petroleum benzene, ligroin, etc.).
また、この有効画分を採り出した残りの水溶液を、水
及びある種の有機溶剤に水を飽和させたものを使用する
ことにより振盪抽出し、水洗し、残分である有機溶剤層
に移行する画分の溶剤を留去したものも、有効画分即ち
有効成分として用いることができる。この有効画分は上
記の有効画分とは、物理化学的性質が異なり、検出され
る成分も異なるものである。The remaining aqueous solution obtained by extracting the effective fraction is shake-extracted by using water and a certain organic solvent saturated with water, washed with water, and transferred to an organic solvent layer as a residue. The solvent obtained by distilling off the solvent of the fraction to be used can also be used as an effective fraction, that is, an active ingredient. This effective fraction differs from the above-mentioned effective fraction in the physicochemical properties and the detected components are also different.
投与量は、生薬の原末重量で換算して0.001mg/体重kg
/日〜100g/体重kg/日の範囲である。この量は予防剤と
して用いる場合と治療剤として用いる場合では異なり、
一般的には後者の方が投与量は多くなる。The dose is 0.001 mg / kg of body weight in terms of the weight of the crude drug.
/ Day to 100 g / kg body weight / day. This amount is different when used as a prophylactic and therapeutic agent,
Generally, the latter dose will be higher.
投与方法は、経口投与または非経口投与することがで
き、非経口投与としては筋肉投与、腹腔内投与、桂皮投
与、経鼻投与、静脈内投与等が可能である。The method of administration can be oral or parenteral, and parenteral administration can be intramuscular, intraperitoneal, cinnamon, nasal, intravenous, and the like.
[発明の効果] 以上詳述したように、本発明によればクロストリジウ
ム パーフリンゲンス感染症の有効な予防及び治療剤並
びに有効な予防及び治療方法が提供される。[Effects of the Invention] As described in detail above, the present invention provides an effective agent for preventing and treating Clostridium perfringens infection and an effective method for preventing and treating the disease.
本発明の予防及び治療剤は生薬またはそれから得られ
るエキス等を主薬とするため、抗生物質等の場合の耐性
菌の発生や副作用の問題が全くなく、安心して投与する
ことができる。Since the prophylactic and therapeutic agent of the present invention is mainly composed of a crude drug or an extract obtained therefrom, there is no problem of the occurrence of resistant bacteria or side effects in the case of antibiotics and the like, and the agent can be administered with confidence.
また、動物が肉用動物、卵及び乳を生産する動物であ
っても、薬剤の残留による人体への影響の心配もない。Moreover, even if the animal is a meat animal, an animal that produces eggs and milk, there is no concern about the effect of the residual drug on the human body.
さらに、抗生物質等を用いる場合に比べて安価に同疾
病を予防及び治療することができる。Furthermore, the disease can be prevented and treated at a lower cost than when an antibiotic or the like is used.
以下本発明を試験例及び実施例によりさらに詳しく説
明する。Hereinafter, the present invention will be described in more detail with reference to Test Examples and Examples.
試験例 1 Clostridium perfringens(鳥由来のもの及び豚由来
のもの)の各種生薬に対する感受性を調べた。Test Example 1 The sensitivity of Clostridium perfringens (bird-derived and pig-derived) to various crude drugs was examined.
各種生薬を、生薬に対し7倍量の50%エタノール水溶
液中に加え、16時間抽出してアルコール抽出物とした。Various crude drugs were added to a 50% aqueous ethanol solution 7 times the amount of the crude drug and extracted for 16 hours to obtain an alcohol extract.
抽出物を直径8mmのディスクに25μlずつしみ込ませ
乾燥させた。このディスクをClostridium perfringens
(鳥由来のもの及び豚由来のもの)の菌株を塗ったミュ
ーラー・ヒントン寒天培地に置き、37℃で18時間嫌気培
養した後阻止円の直径を測定した。The extract was infiltrated into an 8 mm diameter disk by 25 μl and dried. Insert this disc into Clostridium perfringens
(Bird-derived and pig-derived) strains were placed on a Mueller-Hinton agar medium, cultured anaerobically at 37 ° C. for 18 hours, and the diameter of the inhibition circle was measured.
次にその試験結果を示せば表1のとおりである。 Next, Table 1 shows the test results.
実施例 1 基礎飼料 とうもろこし 450重量部 マ イ ロ 260重量部 大 豆 粕 190重量部 魚 粉 50重量部 イエローグリス 30重量部 炭酸カルシウム 7重量部 第3りん酸カルシウム 6重量部 食 塩 2重量部 プレミックス 5重量部 前記基礎飼料にオウレン粉末を重量比で0.5%添加し
た供試飼料とした。 Example 1 Basic Feed Corn 450 parts by weight Micro 260 parts by weight Soybean meal 190 parts by weight Fish meal 50 parts by weight Yellow grease 30 parts by weight Calcium carbonate 7 parts by weight Calcium tertiary phosphate 6 parts by weight Salt 2 parts by weight Pre Mix 5 parts by weight A test feed was prepared by adding 0.5% by weight of a powder of uren to the above basic feed.
28日令の健康な鶏760羽に前記供試飼料を自由に摂餌
させた。試験開始から35日間におけるクロストリジウム
・パーフリンゲンスの野外感染により死亡した鶏の羽数
を観察した。なお対照区は供試飼料の代わりに基礎飼料
を与えた。The test feed was freely fed to 760 healthy 28-day-old chickens. The number of chickens that died from field infection with Clostridium perfringens for 35 days from the start of the test was observed. In the control group, a basal feed was given instead of the test feed.
その結果クロストリジウム・パーフリンゲンス野外感
染で死亡した鶏の羽数は本発明の試験区では2羽であっ
たのに対し、対照区は58羽であった。As a result, the number of chickens that died from the Clostridium perfringens field infection was 2 in the test plot of the present invention, while the number of chickens in the control plot was 58.
実施例 2〜42 実施例1においてオウレンの代わりに下記表2に示し
た生薬を0.6%添加した以外は実施例1と同様に行なっ
た。Examples 2-42 The same procedures as in Example 1 were carried out except that the crude drugs shown in Table 2 below were added in an amount of 0.6% in place of the urethane.
次にその試験結果を示せば表2のとおりである。 Next, the test results are shown in Table 2.
実施例 44 カンゾウ、ヨモギ、オウレン、オウゴン、オウバク、
ゲンノショウコ、コウボク、タンジン、チモ、ダイオ
ウ、チョウジ、ジョテイ、ケイガイ、ケイヒ、ゲンジ
ン、ケツメイシ、ビワヨウ、ボウフウ、ホップ、ソヨ
ウ、ヨウバイヒ、レンギョウ、アロエ、ギョウタン、イ
レイセン、ウバイ、エンメイソウ、シャゼンソウ、シン
イ、インチンコウ、ジンコウ、センキュウ、コウホン、
ゴバイシ、サンシュユ、シコン、コオウレン、シャクヤ
ク、キンオウシ、タイム、シロナンテン、チユ及びマオ
ウの各々を1kgとり、これを夫々10の水に入れ、100℃
で1時間抽出した。各々の水抽出物を1000倍に希釈し抽
出エキスとした。 Example 44 Licorice, mugwort, spinach, ogre, oak,
Gennoshoko, Koboku, Tanjin, Chimo, Daioh, Coji, Jotei, Keigai, Keihi, Genjin, Ketsumeishi, Biwayou, Bohu, Hop, Soyoo, Yojibaig, Forsythia, Aloe, Gyotan, Iraisen, Ubai, Emmaiso, Shazensou, Shinyin, Shinyin Ginko, senkyu, kohon,
Take 1 kg each of Gobishi, Sanshuyu, Sicon, Kourouen, Peony, Kinuushi, Thyme, Shironanten, Chiyu and Ephedra, put them in 10 pieces of water, 100 ° C
For 1 hour. Each water extract was diluted 1000 times to obtain an extract.
28日令の健康な鶏を485羽使用し、抽出エキスを水の
代わりに給与した。飼料は実施例1で使用したものと同
じ基礎飼料を用いた。また対照区は抽出エキスに代えて
水を与えた。このようにして試験開始から35日間飼育し
その時のクロストリジウム パーフリンゲンス野外感染
による死亡羽数を観察した。その結果全ての試験区で対
照区よりクロストリジウム パーフリンゲンス感染によ
る死亡羽数が少なかった。Using 485 healthy chickens aged 28 days, the extract was fed instead of water. As the feed, the same basic feed as that used in Example 1 was used. The control group was given water instead of the extract. In this way, the animals were reared for 35 days from the start of the test, and the number of dead birds due to Clostridium perfringens field infection at that time was observed. As a result, the number of dead birds due to Clostridium perfringens infection was smaller in all the test plots than in the control plot.
実施例 45 基礎飼料 とうもろこし 450重量部 マ イ ロ 310重量部 大 豆 粕 146重量部 なたね粕 30重量部 魚 粉 15重量部 肉 骨 粉 10重量部 イエローグリス 18重量部 炭酸カルシウム 5重量部 りん酸カルシウム 8重量部 食 塩 3重量部 プレミックス 5重量部 前記基礎飼料にオウレン粉末を重量比で0.5%添加
し、供試飼料とした。この供試飼料を30日令の健康な豚
50頭に自由に摂餌させ、60日間飼育した。Example 45 Basic feed Corn 450 parts by weight Microscopically 310 parts by weight Soybean meal 146 parts by weight Seaweed meal 30 parts by weight Fish meal 15 parts by weight Meat and bone powder 10 parts by weight Yellow grease 18 parts by weight Calcium carbonate 5 parts by weight Phosphoric acid 8 parts by weight of calcium 3 parts by weight of salt 3 parts by weight of premix 5% by weight of the above-mentioned basic feed was added with 0.5% by weight of a powder of uren to prepare a test feed. Use this test feed as a 30-day-old healthy pig
Fifty animals were fed freely and kept for 60 days.
また対照区は供試飼料に代えて基礎飼料を与えた。 In the control group, a basal feed was given instead of the test feed.
そして試験期間中のクロストリジウム パーフリンゲ
ンス野外感染で死亡した豚の頭数及びクロストリジウム
パーフリンゲンス野外感染による下痢の延べ日数を観
察した。その結果クロストリジウム パーフリンゲンス
野外感染で死亡した豚の頭数は本発明の試験区では0頭
であったのに対し、対照区では7頭であった。また試験
期間中に下痢をした豚の延べ頭数は試験区では5頭/300
0頭であったのに対し対照区では111頭/3000頭であっ
た。Then, the number of pigs that died from the Clostridium perfringens field infection during the test period and the total number of diarrhea days due to the Clostridium perfringens field infection were observed. As a result, the number of pigs that died due to Clostridium perfringens field infection was 0 in the test plot of the present invention, whereas it was 7 in the control plot. The total number of pigs with diarrhea during the test period was 5/300 in the test plot.
The number of animals was 0, whereas that of the control group was 111/3000.
実施例46〜87 実施例45においてオウレン粉末の代わりに下記表3に
示す生薬を基礎飼料に0.6%添加した以外は実施例45と
同様になった。Examples 46 to 87 The procedures were the same as in Example 45, except that the crude drug shown in Table 3 below was added to the basal feed in an amount of 0.6% in place of the powdered urine.
次にその試験結果を示せば表3のとおりである。 Next, the test results are shown in Table 3.
実施例 88 カンゾウ、ヨモギ、オウレン、オウゴン、オウバク、
ゲンノショウコ、コウボク、タンジン、チモ、ダイオ
ウ、チョウジ、ジョテイ、ケイガイ、ケイヒ、ゲンジ
ン、ケツメイシ、ビワヨウ、ボウフウ、ホップ、ソヨ
ウ、ヨウバイヒ、レンギョウ、アロエ、ギョウタン、イ
レイセン、ウバイ、エンメイソウ、シャゼンソウ、シン
イ、インチンコウ、ジンコウ、センキュウ、コウホン、
ゴバイシ、サンシュユ、シコン、コオウレン、シャクヤ
ク、キンオウシ、タイム、シロナンテン、チユ及びマオ
ウの各々を1kgとり、これを夫々10の水に入れ、100℃
で1時間抽出した。各々の水抽出物を1000倍に希釈し、
抽出エキスとした。 Example 88 Licorice, mugwort, orange, ogre, oak,
Gennoshoko, Koboku, Tanjin, Chimo, Daioh, Coji, Jotei, Keigai, Keihi, Genjin, Ketsumeishi, Biwayou, Bohu, Hop, Soyoo, Yojibaig, Forsythia, Aloe, Gyotan, Iraisen, Ubai, Emmaiso, Shazensou, Shinyin, Shinyin Ginko, senkyu, kohon,
Take 1 kg each of Gobishi, Sanshuyu, Sicon, Kourouen, Peony, Kinuushi, Thyme, Shironanten, Chiyu and Ephedra, put them in 10 pieces of water, 100 ° C
For 1 hour. Dilute each water extract 1000 times,
The extract was used.
30日令の健康な豚を1区50頭使用し、試験区には抽出
エキスを水の代わりに給与し、対照区は水を与えた。飼
料は実施例45で使用したものと同じ基礎飼料を用いた。
このようにして60日間飼育し各区のクロストリジウム
パーフリンゲンス野外感染による死亡頭数及び下痢の頭
数を観察した。50 pigs, 30 days old, were used in one group, and the test group was provided with the extract instead of water, and the control group was provided with water. As the feed, the same basic feed as that used in Example 45 was used.
Clostridium bred for 60 days in this manner
The number of deaths and the number of diarrhea due to Perfringens field infection were observed.
その結果全ての試験区で対照区より死亡頭数及び下痢
の頭数は少なかった。As a result, the number of dead animals and the number of diarrhea in all the test plots were smaller than those in the control plots.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.6 識別記号 庁内整理番号 FI 技術表示箇所 A61K 35/78 A61K 35/78 K E N V F H B AEV AEVT (56)参考文献 特開 昭61−210038(JP,A) 特開 昭48−58115(JP,A) 特開 昭51−61612(JP,A) 特開 昭62−59214(JP,A) 特開 昭62−12720(JP,A) 特開 昭57−26549(JP,A) 特開 昭57−132847(JP,A) 赤松金芳著、「新訂和漢薬」、医歯薬 出版株式会社、昭和55年10月15日、第1 版第5刷発行、第327,1,8,11, 454,110,301,314,433,109,589, 493,209,160,103,421,92,350, 358,196,510,105,529,155,784, 461,369,97,79,432,5,218,189, 197,268,178,120,90,457,381, 114,442,386,655頁参照──────────────────────────────────────────────────の Continuation of the front page (51) Int.Cl. 6 Identification code Agency reference number FI Technical display location A61K 35/78 A61K 35/78 KENVFHB AEV AEVT (56) References JP-A Sho 61-210038 (JP, A) JP-A-48-58115 (JP, A) JP-A-51-61612 (JP, A) JP-A-62-259214 (JP, A) JP-A-62-12720 (JP, A A) JP-A-57-26549 (JP, A) JP-A-57-132847 (JP, A) Kanayoshi Akamatsu, Shinshin Wakan Yakuhin, Medical and Dental Medicine Publishing Co., Ltd., October 15, 1980 , 1st edition, 5th printing, 327, 1, 8, 11, 454, 110, 301, 314, 433, 109, 589, 493, 209, 160, 103, 421, 92, 350, 358, 196, 510,105,529,155,784,461,369,97,79,432,5,218,189,197,268,178,120,90,457,381,114,442,38 See page 6,655
Claims (5)
オウバク、ゲンノショウコ、コウボク、タンジン、チ
モ、ダイオウ、チョウジ、ジョテイ、ケイガイ、ケイ
ヒ、ゲンジン、ケツメイシ、ビワヨウ、ボウフウ、ホッ
プ、ソヨウ、ヨウバイヒ、レンギョウ、アロエ、ギュウ
タン、イレイセン、ウバイ、エンメイソウ、シャゼンソ
ウ、シンイ、インチンコウ、ジンコウ、センキュウ、コ
ウホン、ゴバイシ、サンシュユ、シコン、コオウレン、
シャクヤク、キンオウシ、タイム、シロナンテン、チユ
及びマオウからなる群から選択された1種または2種以
上の生薬を含有する家畜及び家禽のクロストリジウム
パーフリンゲンス感染症の予防及び治療剤。Claims: 1. A liquorice, mugwort, spinach, ogre,
Obak, Gennoshoko, Koboku, Tanjin, Chimo, Rhubarb, Coji, Jotei, Keigai, Keihi, Genjin, Ketsumeishi, Biwayou, Bowhu, Hop, Soyou, Yowaihi, Forsythia, Aloe, Gyutan, Ireisen, Ubai, Emmaiso, Shazensou Clinch, Jinko, Senkyu, Kouhon, Gobishi, Sanshuyu, Sicon, Kouren,
Clostridium of livestock and poultry containing one or more crude drugs selected from the group consisting of peonies, bullfinch, thyme, shironanten, chiyu and ephedra
Agent for preventing and treating Perfringens infection.
1項に記載の予防及び治療剤。2. The prophylactic and therapeutic agent according to claim 1, wherein the crude drug is in bulk form.
または水で抽出した生薬エキス及び/またはそれから得
られた生薬有効成分である特許請求の範囲第1項に記載
の予防及び治療剤。3. The preventive and therapeutic agent according to claim 1, wherein the crude drug is an organic solvent, a mixture of water and an organic solvent, or a crude drug extract extracted with water and / or a crude drug active ingredient obtained therefrom. .
範囲第1項に記載の予防及び治療剤。4. The preventive and therapeutic agent according to claim 1, wherein the crude drug is incorporated in feed.
請求の範囲第1項に記載の予防及び治療剤。5. The preventive and therapeutic agent according to claim 1, wherein the livestock and poultry are chickens, pigs, cows and sheep.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62328331A JP2599161B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultry |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62328331A JP2599161B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultry |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH01172341A JPH01172341A (en) | 1989-07-07 |
| JP2599161B2 true JP2599161B2 (en) | 1997-04-09 |
Family
ID=18209036
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62328331A Expired - Lifetime JP2599161B2 (en) | 1987-12-26 | 1987-12-26 | Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultry |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2599161B2 (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3338928B2 (en) | 1998-06-06 | 2002-10-28 | 機能研産業株式会社 | Anticoccidial agent |
| JP2006333703A (en) * | 2005-05-06 | 2006-12-14 | Daicho Kikaku:Kk | Animal feed additive and animal feed |
| WO2009047881A1 (en) | 2007-10-12 | 2009-04-16 | Co., Ltd. Kraft | Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight |
| WO2010067883A1 (en) | 2008-12-12 | 2010-06-17 | 出光興産株式会社 | Feed for preventing and/or treating diseases due to clostridium sp. bacteria in livestock, and anti-clostridium agent |
| KR101369255B1 (en) * | 2007-03-16 | 2014-03-05 | 원광대학교산학협력단 | A veterinary composition comprising extracts of Galla Rhois and Moutan Cortex Radicis showing antibacterial and antiviral activity |
| CN106036153A (en) * | 2016-06-03 | 2016-10-26 | 广西农业职业技术学院 | Chicken feed added with agalloch eaglewood leaf meal |
| KR20190029882A (en) * | 2017-09-13 | 2019-03-21 | (주)이에프씨 | Preparation Method of Drinking Water Composition for Poultry Farming and Drinking Water Composition thereof |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH01285160A (en) * | 1988-05-12 | 1989-11-16 | Itochu Shiryo Kk | Pig feed |
| US6251461B1 (en) * | 1997-10-10 | 2001-06-26 | S. S. Steiner, Inc. | Antimicrobial activity of hops extract against Clostridium botulinum, Clostridium difficile and Helicobacter pylori |
| US20060134248A1 (en) | 2002-09-23 | 2006-06-22 | Maye John P | Hop acids as a replacement for antibiotics in animal feed |
| PL1722635T3 (en) | 2004-02-23 | 2016-06-30 | Sss Acquisition Llc | Feeds containing hop acids and uses thereof as supplements in animal feeds |
| CN1327781C (en) * | 2005-08-16 | 2007-07-25 | 长沙绿叶生物科技有限公司 | Health caring feed stuff for healing pig asthma and its using method |
| JP5101081B2 (en) * | 2006-10-31 | 2012-12-19 | 日清丸紅飼料株式会社 | Feed for prevention and / or treatment of coccidiosis and clostridiasis |
| ES2523667T3 (en) * | 2007-06-29 | 2014-11-28 | Dsm Ip Assets B.V. | Use of benzoic acid and thymol, eugenol and piperidine in animal feed |
| EP2187762B1 (en) * | 2007-09-11 | 2015-01-21 | DSM IP Assets B.V. | Use of sesquiterpenes as feed additives in animal feed |
| KR100923771B1 (en) * | 2007-10-11 | 2009-10-27 | 충북바이오축산 영농조합법인 | Poultry rearing method using eco-friendly poultry feed |
| KR101923254B1 (en) | 2011-10-28 | 2018-11-28 | 킴벌리-클라크 월드와이드, 인크. | Sporicidal formulation including amine oxide surfactant and a mixture of oxidants |
| BR112014010152A2 (en) | 2011-10-28 | 2017-04-25 | Kimberly Clark Co | sporicidal formulation and handkerchief |
| CN108077635A (en) * | 2017-12-22 | 2018-05-29 | 李春慧 | A kind of additive agent for chicken feed and preparation method thereof |
| JP6985135B2 (en) * | 2017-12-25 | 2021-12-22 | 小林製薬株式会社 | Regulatory T cell differentiation inhibitor and immunomodulatory composition |
| CN112998127B (en) * | 2021-04-26 | 2024-06-25 | 长沙博海生物科技有限公司 | Feed additive for improving content of nervonic acid and arginine in animal body |
| CN117323319B (en) * | 2022-06-27 | 2025-09-30 | 广西大学 | Traditional Chinese medicine monomer composition for preventing and controlling necrotic enteritis in chickens |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5228922A (en) * | 1975-08-27 | 1977-03-04 | Takeo Ooyama | Medicine mixture for animals |
-
1987
- 1987-12-26 JP JP62328331A patent/JP2599161B2/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| 赤松金芳著、「新訂和漢薬」、医歯薬出版株式会社、昭和55年10月15日、第1版第5刷発行、第327,1,8,11,454,110,301,314,433,109,589,493,209,160,103,421,92,350,358,196,510,105,529,155,784,461,369,97,79,432,5,218,189,197,268,178,120,90,457,381,114,442,386,655頁参照 |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3338928B2 (en) | 1998-06-06 | 2002-10-28 | 機能研産業株式会社 | Anticoccidial agent |
| JP2006333703A (en) * | 2005-05-06 | 2006-12-14 | Daicho Kikaku:Kk | Animal feed additive and animal feed |
| KR101369255B1 (en) * | 2007-03-16 | 2014-03-05 | 원광대학교산학협력단 | A veterinary composition comprising extracts of Galla Rhois and Moutan Cortex Radicis showing antibacterial and antiviral activity |
| WO2009047881A1 (en) | 2007-10-12 | 2009-04-16 | Co., Ltd. Kraft | Agent for increasing body weight, animal feed for increasing body weight and health food for increasing body weight |
| WO2010067883A1 (en) | 2008-12-12 | 2010-06-17 | 出光興産株式会社 | Feed for preventing and/or treating diseases due to clostridium sp. bacteria in livestock, and anti-clostridium agent |
| KR20110100272A (en) | 2008-12-12 | 2011-09-09 | 이데미쓰 고산 가부시키가이샤 | Feed for the prevention and / or treatment of diseases caused by Clostridium bacteria in domestic animals, and anti-clostridium |
| CN106036153A (en) * | 2016-06-03 | 2016-10-26 | 广西农业职业技术学院 | Chicken feed added with agalloch eaglewood leaf meal |
| KR20190029882A (en) * | 2017-09-13 | 2019-03-21 | (주)이에프씨 | Preparation Method of Drinking Water Composition for Poultry Farming and Drinking Water Composition thereof |
| KR101974924B1 (en) * | 2017-09-13 | 2019-05-03 | (주)이에프씨 | Preparation Method of Drinking Water Composition for Poultry Farming and Drinking Water Composition thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01172341A (en) | 1989-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2599161B2 (en) | Preventive and therapeutic agent for Clostridium perfringens infection in livestock and poultry | |
| JP2599159B2 (en) | Prevention and treatment of bovine mastitis | |
| US20120164249A1 (en) | Chinese herbal medicine composition used for antiinflammation, detumescence and acesodyne, and preparation method and use thereof | |
| JP3007665B2 (en) | Preventive and therapeutic agent for coronavirus infection and disinfectant | |
| CN104256168B (en) | One boar functional feed and preparation method thereof | |
| MX2011006273A (en) | FOOD TO PREVENT AND / OR TREAT DISEASES DUE TO BACTERIA CLOSTRIDIUM SP. IN LIVESTOCK AND ANTI-CLOSTRIDIUM AGENT. | |
| JP2603977B2 (en) | Prevention and treatment of Pasteurella haemolytica infection in livestock | |
| CN103478508A (en) | Chinese medicinal composition and feed for improving chicken immunity and preparation method of composition and feed | |
| CN106344648A (en) | Thymus plant extract and application thereof | |
| JP2535559B2 (en) | Agent for the prevention and treatment of pruritus in fish | |
| JP2599160B2 (en) | Preventive and therapeutic agent for staphylococcal disease in chickens | |
| CN110721095B (en) | Herbal oral bacteriostatic spray containing propolis and preparation method thereof | |
| JP2535555B2 (en) | Agent for preventing and treating streptococcal disease in fish | |
| JP2599152B2 (en) | Agent for prevention and treatment of pasturellosis in pigs | |
| CN108403939B (en) | Chinese medicinal compound preparation for treating hemorrhoids and constipation and Chinese medicinal composition used by same | |
| WO2020155318A1 (en) | Traditional chinese medicine preparation for treatment of bacterial respiratory tract disease in livestock and production technique thereof | |
| CN109645232A (en) | A kind of Chinese herbal medicine composite feed additive for treating animal diarrhea | |
| CN102188671B (en) | Chinese medicinal preparation for treating chronic cholecystitis | |
| CN102813713B (en) | Rhizoma dryopteris crassirhizomae and fructus crataegi composition, preparation method and application of composition | |
| JP2535557B2 (en) | Agent for preventing and treating Vibrio alderi infection of fish | |
| JP2599157B2 (en) | Preventive and therapeutic agent for swine dysentery | |
| JP2535556B2 (en) | Agent for prevention and treatment of vibrio disease in fish | |
| JP2535558B2 (en) | Agent for prevention and treatment of fin fin disease of fish | |
| JP2599154B2 (en) | Agent for prevention and treatment of haemophilus infection in pigs | |
| CN113209011A (en) | Traditional Chinese medicine oral liquid for preventing and treating porcine viral diarrhea diseases and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| EXPY | Cancellation because of completion of term |